Swiss National Bank Krystal Biotech, Inc. Transaction History

Swiss National Bank

$146 Billion
Q4 2024

A detailed history of Swiss National Bank transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Swiss National Bank holds 42,400 shares of KRYS stock, worth $6.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,400

Previous 39,100 8.44%

Holding current value

$6.5 Million

Previous $7.11 Million 6.58%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$156.64 - $199.61 $516,911 - $658,713	3,300 Added 8.44%	42,400 $6.64 Million
Q3 2024 Nov 07, 2024	BUY	$174.7 - $213.66 $506,629 - $619,614	2,900 Added 8.01%	39,100 $7.11 Million
Q1 2024 May 07, 2024	BUY	$108.01 - $179.35 $32,403 - $53,805	300 Added 0.84%	36,200 $6.44 Million
Q4 2023 Feb 06, 2024	SELL	$96.0 - $128.29 $336,000 - $449,015	-3,500 Reduced 8.88%	35,900 $4.45 Million
Q3 2023 Nov 08, 2023	SELL	$108.51 - $130.22 $292,977 - $351,594	-2,700 Reduced 6.41%	39,400 $4.57 Million
Q2 2023 Aug 09, 2023	BUY	$78.48 - $130.32 $251,136 - $417,024	3,200 Added 8.23%	42,100 $4.94 Million
Q1 2023 May 10, 2023	SELL	$72.39 - $84.27 $325,755 - $379,215	-4,500 Reduced 10.37%	38,900 $3.11 Million
Q4 2022 Feb 08, 2023	BUY	$63.14 - $79.9 $50,512 - $63,920	800 Added 1.88%	43,400 $3.44 Million
Q3 2022 Nov 09, 2022	BUY	$64.85 - $82.4 $90,789 - $115,360	1,400 Added 3.4%	42,600 $2.97 Million
Q1 2022 May 09, 2022	BUY	$51.99 - $72.11 $145,572 - $201,908	2,800 Added 7.29%	41,200 $2.74 Million
Q4 2021 Feb 08, 2022	BUY	$39.81 - $88.24 $262,746 - $582,384	6,600 Added 20.75%	38,400 $2.69 Million
Q3 2021 Nov 08, 2021	BUY	$52.01 - $71.77 $20,804 - $28,708	400 Added 1.27%	31,800 $1.66 Million
Q2 2021 Aug 06, 2021	BUY	$62.14 - $81.82 $130,494 - $171,822	2,100 Added 7.17%	31,400 $2.14 Million
Q1 2021 May 07, 2021	BUY	$59.42 - $85.46 $23,768 - $34,184	400 Added 1.38%	29,300 $2.26 Million
Q3 2020 Nov 09, 2020	BUY	$37.76 - $48.49 $18,880 - $24,245	500 Added 1.76%	28,900 $1.24 Million
Q2 2020 Aug 05, 2020	BUY	$37.03 - $60.0 $244,398 - $396,000	6,600 Added 30.28%	28,400 $1.18 Million
Q1 2020 May 08, 2020	BUY	$35.02 - $65.64 $10,506 - $19,692	300 Added 1.4%	21,800 $943,000
Q4 2019 Feb 06, 2020	BUY	$33.17 - $65.23 $33,170 - $65,230	1,000 Added 4.88%	21,500 $1.19 Million
Q2 2019 Aug 02, 2019	BUY	$27.2 - $41.2 $557,600 - $844,600	20,500 New	20,500 $826,000

Others Institutions Holding KRYS

# of Institutions

297

Shares Held

24.3M

Call Options Held

388K

Put Options Held

233K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $3.93B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Krystal Biotech, Inc. Transaction History